17 Jul 2023 argenx reports positive topline data from ADHERE study of VYVGART Hytrulo in patients with chronic inflammatory demyelinating polyneuropathy Member news
11 Jul 2023 Aphea.Bio secures € 70 million Series C Funding, accelerating the company’s commercialisation efforts Member news
10 Jul 2023 Sequana Medical announces first patient enrolled in MOJAVE, a US randomized controlled Phase 1/2a study of DSR® 2.0 for treatment of congestive heart failure Member news
03 Jul 2023 AMA issues CPT III code for icometrix’ AI-related brain MRI quantification software Member news
03 Jul 2023 KU Leuven research generates new insights into the development of and care for 'the little brain' of the gut Member news
30 Jun 2023 argenx and Zai Lab announce approval of VYVGART® (efgartigimod alfa injection) for generalized myasthenia gravis in China Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
